<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/automated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/automated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2017-04-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2017-04-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/automated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o/"},"url":"https://clinicaltree.github.io/posts/automated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o/"}</script><title>Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Automated “Bone Subtraction” Image Analysis Software Package for Improved and Faster CT Monitoring of Longitudinal Spine Involvement in Patients with Multiple Myeloma</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1493571600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 30, 2017 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Marius Horger MD</a> </em>, <em> <a href="">Hendrick Ditt PhD</a> </em>, <em> <a href="">Shu Liao PhD</a> </em>, <em> <a href="">Katja Weisel MD</a> </em>, <em> <a href="">Jan Fritz MD</a> </em>, <em> <a href="">Wolfgang M. Thaiss MD</a> </em>, <em> <a href="">Sascha Kaufmann MD</a> </em>, <em> <a href="">Konstantin Nikolaou MD</a> </em>, <em> <a href="">Christopher Kloth MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2180 words"> <em>12 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The study aimed to assess the diagnostic benefit of a novel computed tomography (CT) post-processing software generating subtraction maps of longitudinal non-enhanced CT examinations for monitoring the course of myeloma bone disease in the spine.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The local institutional review board approved the retrospective data evaluation. Included were 82 consecutive myeloma patients (46 male; mean age, 65.08 ± 9.76) who underwent 188 repeated whole-body reduced-dose Multislice Detector Computed Tomography (MDCT) at our institution between December 2013 and January 2016. Lytic bone lesions were categorized as new or enlarging versus stable. Bone subtraction maps were read in combination with corresponding 1-mm source images comparing results to those of standard image reading of 5-mm axial and 2-mm multiplanar reformat reconstructions (MPR) scans and hematologic markers, and classified as either progressive disease (PD) or stable disease (SD or remission). The standard of reference was 1-mm axial CT image reading + hematologic response both confirmed at follow-up. For statistical purposes, we subgrouped the hematologic response categories similarly to those applied for CT imaging (progression vs stable/response).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>According to the standard of reference, 16 patients experienced PD and 66 SD at follow-up. Th sensitivity, specificity, and accuracy for axial 5 mm + 2 mm MPR image versus bone subtraction maps in a “lesion-by-lesion” reading were 97.6%, 92.3%, and 97.2% versus 97.8%, 96.7%, and 97.7%, respectively. The use of bone subtraction maps resulted in a change of response classification in 9.7% of the patients ( <em>n</em> = 8) versus 5 mm + 2 mm MPR image reading from SD to PD. Bone sclerosis lesions were detected in 52 out of 82 patients (63.4%). The reading time was significantly lower with the software bone subtraction compared to standard reading ( <em>P</em> &lt; 0.01) and 1-mm image reading ( <em>P</em> &lt; 0.001).</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Accuracy of bone subtraction maps reading for monitoring multiple myeloma is slightly increased over that of conventional axial + MPR image reading and significantly speeds up the reading time.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Multiple myeloma is a malignant hematologic disease of mature B cells with an often guarded prognosis. The disease is characterized by an overproduction of monoclonal immunoglobulins or light-chain molecules. One major feature is myeloma bone disease (MBD), which manifests as focal or diffuse generalized bone destruction. A misbalance of osteoblasts and osteoclasts function results in an overall increased osteoclast activity and subsequent bone resorption as well as disabled osteoblasts . As a consequence, these osteolyses do not heal in the majority of patients .On first diagnosis, almost 80% of the patients with multiple myeloma present with lytic bone lesions , which due to an often high number and small size can pose a challenge for radiological detection. In particular at follow-up and during treatment, the determination of MBD progression can be time-consuming and potentially inaccurate.</p><p>In the last decades, post-processing techniques, such as multiplanar reconstructions and the use of thin-slice reconstructions, significantly improved lesion detection. In multiple myeloma, typically the axial skeleton is involved first as the disease predominates in regions of predominant red marrow. Typically, myeloma first involves the bone marrow, which follows bone destruction as the tumor nests enlarge and the dense trabecular architecture of the cancellous bone limits their expansion. Before bone destruction becomes evident on radiographs or even computed tomography (CT), magnetic resonance imaging proves superior for the detection of infiltrative medullary lesions. Nevertheless, CT can provide helpful information during or after therapy, specifically for the detection of residual abnormalities, which are concerning for localized relapse . Although many myeloma patients can be monitored reliably with hematologic parameters such as M-gradient, the non-secretory group of patients does not secrete paraproteins and is therefore difficult to monitor. In this group of patients, imaging plays an important diagnostic role. Moreover, progression of MBD is often not affected by chemotherapy even in responding patients . For this reason, the detection of changes occurring in the axial skeleton at follow-up is critical for accurate assessment of progressive disease. CT is the most accurate technique for imaging assessment of bone. Several new techniques have been tested in the last years with the goal to increase detection of bone changes during disease surveillance. Some researchers applied automatic detection of bone metastases in the thoracolumbar spine and visualization of bone metastases with maximum intensity projection and surface-shaded display techniques . In a small animal myeloma model, Evans et al. tested a fully automatic image analysis method created to detect osteolyses in the cortical bone of the tibia .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="subjects"><span class="mr-2">Subjects</span><a href="#subjects" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patients’ Demographics</p><p>No. of Patients_n_ = 82 100% Age, years, mean ± SD 65.08 ± 9.76 – Range 38–81 – Age at initial diagnosis, mean ± SD 61.21 ± 10.36 – Male 46 56.09 Female 36 43.91 Durie and Salmon I 23 28.0 II 11 13.4 III 48 58.6 ISS I 42 51.2 II 13 15.8 III 27 33.0</p><p>ISS, International Staging System; SD, standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Maintenance Therapy Regimens at Time Point of Follow-up Examination</p><p><em>n</em> % Overall_82<em>_100</em> Primary therapy 34 41.4 Lenalidomide and dexamethasone_10<em>_12.1</em> VCD_7<em>_8.9</em> VPM_4<em>_4.8</em> Pomalidomide and dexamethasone_4<em>_4.8</em> Bortezomib and dexamethasone_3<em>_3.6</em> Revlimid and dexamethasone_2<em>_2.4</em> Melphalan_2<em>_2.4</em> Cyclophosphamide mono_1<em>_1.2</em> Daratumumab + bortezomib + dexamethasone_1<em>_1.2</em> Remission control/maintenance therapy 18 19.3 Lenalidomide 8 9.7 Pomalidomide/Dexamethasone 4 4.8 Thalidomide 2 2.4 Bortezomib 1 1.2 Carfilzomib/Dexamethasone 1 1.2 No therapy 30 39.3</p><p>VCD, bortezomib + cyclophosphamide + dexamethasone; VPM, bortezomib + melphalan + dexamethasone.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-image-protocol"><span class="mr-2">CT Image Protocol</span><a href="#ct-image-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-image-post-processing"><span class="mr-2">CT Image Post-processing</span><a href="#ct-image-post-processing" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/0_1s20S107663321630424X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/0_1s20S107663321630424X.jpg" alt="Figure 1, Sagittal MPR of bone subtraction map (a) + corresponding anatomic CT image at the level of the lumbar spine acquired at prior examination (b) , as well as zoomed sagittal scans from the current (c) and prior (d) CT examination of a 71-year-old male patient with multiple myeloma after high-dose chemotherapy + autologous stem cell transplantation with no maintenance therapy at interval. Note that there is a homogenous gray display of the spine with no focal abnormalities (neither lytic nor sclerotic). Follow-up CT ( b and d ) was performed 1 year later. The software package generates whole spine subtraction maps including corresponding morphologic CT images that can be discretionary zoomed for more detailed image viewing. CT, computed tomography; MPR, multiplanar reformat reconstructions." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="standard-of-reference"><span class="mr-2">Standard of Reference</span><a href="#standard-of-reference" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="classification-of-the-disease-course-at-follow-up-based-on-ct-imaging"><span class="mr-2">Classification of the Disease Course at Follow-up Based on CT Imaging</span><a href="#classification-of-the-disease-course-at-follow-up-based-on-ct-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="hematologic-classification-of-the-disease-course-at-follow-up"><span class="mr-2">Hematologic Classification of the Disease Course at Follow-up</span><a href="#hematologic-classification-of-the-disease-course-at-follow-up" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="hematologic-classification-of-the-disease-course"><span class="mr-2">Hematologic Classification of the Disease Course</span><a href="#hematologic-classification-of-the-disease-course" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Overview of Response Categories</p><p>Response Categories Hematologic-based Classification Bone Subtraction CT-based Classification (5-mm axial + 2-mm MPR)<em>n</em> (%)<em>n</em> (%)<em>n</em> (%) Progressive disease (PD) 16 (22.3%) 21 (25.6%) 15 (18.5%) Stable disease (SD) 66 (77.7%) 61 (74.3%) 67 (81.5%)</p><p>CT, computed tomography; MPR, multiplanar reformat reconstructions.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="classification-of-the-disease-course-based-on-ct-imaging"><span class="mr-2">Classification of the Disease Course Based on CT Imaging</span><a href="#classification-of-the-disease-course-based-on-ct-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/1_1s20S107663321630424X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/1_1s20S107663321630424X.jpg" alt="Figure 2, (a–d) A 75-year-old female patient with MM developing small lytic lesions ( long white arrows ) in the lumbar spine at follow-up (6 months later) that were overlooked on axial 5-mm + 2-mm MPR scan reading due to their location near the intervertebral disc. Lytic lesions are marked black in the subtraction map. Note that there are more lytic lesions (eg, in the next vertebra above). The patient had ongoing maintenance therapy with dexamethasone at that time. She developed additional osteolyses in other skeletal regions assessed by whole-body reduced-dose computed tomography, and was therefore correctly classified as progressive disease even by 5-mm + 2-mm MPR scan reading. MM, Multiple Myeloma; MPR, multiplanar reformat reconstructions." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/2_1s20S107663321630424X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/2_1s20S107663321630424X.jpg" alt="Figure 3, (a–d) A 78-year-old male patient with MM developing small lytic lesions ( long white arrows ) at sagittal follow-up (6 months) during treatment with pomalidomide and dexamethasone. These lytic bone lesions were missed on 5-mm + 2-mm MPR scan reading due either to their small size or the close relation to the intervertebral space. Lytic lesions are displayed as black spots in the subtraction map ( white arrow ). MM, Multiple Myeloma; MPR, multiplanar reformat reconstructions." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Overview of Longitudinal Changes in Bone Attenuation in Patients Developing Bone Sclerosis</p><p>Progress (Patients, <em>n</em> = 21) Stable (Patients, <em>n</em> = 61) Baseline Examination Follow-up Examination_P_ Baseline Examination Follow-up Examination_P_ Sclerotic lesions Mean HU 187.85 <strong>±</strong> 229.58 432.76 <strong>±</strong> 173.93 0.001 \* 250.42 <strong>±</strong> 242.87 497.98 <strong>±</strong> 211.39 0.001 \* Min HU −106.23 <strong>±</strong> 240.93 13.33 <strong>±</strong> 226.89 0.001 \* −62.58 <strong>±</strong> 221.13 79.73 <strong>±</strong> 239.42 0.001 \* Max HU 508.23 <strong>±</strong> 284.33 845.54 <strong>±</strong> 254.90 0.001 \* 648.86 <strong>±</strong> 346.49 926.52 <strong>±</strong> 318.31 0.001 \*</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/3_1s20S107663321630424X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/3_1s20S107663321630424X.jpg" alt="Figure 4, A 54-year-old male patient with MM developing sclerotic lesion ( long white arrows ) at follow-up (5 months) after chemotherapy and bisphosphonates. Sclerotic lesions were marked white in the qualitative bone subtraction map. Axial bone subtraction map (a) + prior anatomic CT image at the level of the thoracic spine (b), as well as current (c) and prior (d) axial scans, showing treatment-induced sclerosis of the bone ( arrows ). In the prior CT examination ( b and d ), a large osteolysis involving both vertebral laminae and the spinous process is seen. There was no radiation therapy performed at that site at any time. CT, computed tomography; MM, Multiple Myeloma." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/4_1s20S107663321630424X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AutomatedBoneSubtractionImageAnalysisSoftwarePackageforImprovedandFasterCTMonitoringofLongitudinalSpineInvolvementinPatientswithMultipleMyeloma/4_1s20S107663321630424X.jpg" alt="Figure 5, A 77-year-old male patient with multiple myeloma during active therapy with bortezomib + melphalan + dexamethasone. The two CT examinations were performed at baseline and 3 months later during ongoing treatment. Follow-up CT after 3 months shows sclerosis ( a and c ) in former lytic lesion with secondary pathologic fracture ( b and d ) in left transverse process of the first thoracic vertebra ( white arrow ). Sclerotic lesions were marked white in the qualitative bone subtraction map. CT, computed tomography." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 5</p><p>Lesion Based Sensitivity, Specificity, Accuracy, Positive Predictive Value, and Negative Predictive Value</p><p>Axial 5-mm + 2-mm MPR (%) Axial 1 mm (%) Bone Subtraction (%) Sensitivity 97.6 97.7 97.8 Specificity 92.3 95.2 96.7 Accuracy 97.2 97.4 97.7 Positive predictive value 99.4 99.4 99.4 Negative predictive value 75.0 83.3 88.2</p><p>MPR, multiplanar reformat reconstructions.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="reading-time"><span class="mr-2">Reading Time</span><a href="#reading-time" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="interobserver-agreement"><span class="mr-2">Interobserver Agreement</span><a href="#interobserver-agreement" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Roodman G.D.: Osteoblast function in myeloma. Bone 2011; 48: pp. 135-140.</p><li><p>2. Roodman G.D.: Skeletal imaging and management of bone disease. Hematology Am Soc Hematol Educ Program 2008; 2008: pp. 313-319.</p><li><p>3. Kyle R.A., Gertz M.A., Witzig T.E., et. al.: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: pp. 21-33.</p><li><p>4. Lecouvet F.E., De Nayer P., Garbar C., et. al.: Treated plasma cell lesions of bone with MRI signs of response to treatment: unexpected pathological findings. Skeletal Radiol 1998; 27: pp. 692-695.</p><li><p>5. Gleeson T.G., Moriarty J., Shortt C.P., et. al.: Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol 2009; 38: pp. 225-236.</p><li><p>6. Raje N., Anderson K.C.: Multiple myeloma. Curr Treat Options Oncol 2000; 1: pp. 73-82.</p><li><p>7. O’Connor S.D., Yao J., Summers R.M.: Lytic metastases in thoracolumbar spine: computer-aided detection at CT–preliminary study. Radiology 2007; 242: pp. 811-816.</p><li><p>8. Herman G.T., Coin C.G.: The use of three-dimensional computer display in the study of disk disease. J Comput Assist Tomogr 1980; 4: pp. 564-567.</p><li><p>9. Hohne K.H., Bernstein R.: Correction to “shading 3D-images from CT using gray-level gradients”. IEEE Trans Med Imaging 1986; 5: pp. 165.</p><li><p>10. Evans H.R., Karmakharm T., Lawson M.A., et. al.: Osteolytica: an automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methods. Bone 2016; 83: pp. 9-16.</p><li><p>11. Durie B.G., Kyle R.A., Belch A., et. al.: Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 2003; 4: pp. 379-398.</p><li><p>12. Palumbo A., Avet-Loiseau H., Oliva S., et. al.: Revised International Staging System for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 2015; 33: pp. 2863-2869.</p><li><p>13. Horger M., Pereira P., Claussen C.D., et. al.: Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol 2008; 81: pp. 386-396.</p><li><p>14. Homann G., Mustafa D.F., Ditt H., et. al.: Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard (1)(8)F-FDG-PET/CT. Acad Radiol 2015; 22: pp. 505-512.</p><li><p>15. Viola P., Jones M.: Robust real-time face detection. Int J Comput Vis 2004; 57: pp. 137-154.</p><li><p>16. Viola P.W.W.: Alignment by maximization of mutual information. Int J Comput Vis 1997; 24: pp. 137-154.</p><li><p>17. International Myeloma Working Group: Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: pp. 749-757.</p><li><p>18. Lecouvet F.E., Vande Berg B.C., Michaux L., et. al.: Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209: pp. 653-660.</p><li><p>19. Song I.C., Kim J.N., Choi Y.S., et. al.: Diagnostic and prognostic implications of spine magnetic resonance imaging at diagnosis in patients with multiple myeloma. Cancer Res Treat 2015; 47: pp. 465-472.</p><li><p>20. Horger M., Kanz L., Denecke B., et. al.: The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer 2007; 109: pp. 1617-1626.</p><li><p>21. Schulze M., Weisel K., Grandjean C., et. al.: Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study. AJR Am J Roentgenol 2014; 202: pp. 170-179.</p><li><p>22. Mohty M., Malard F., Mohty B., et. al.: The effects of bortezomib on bone disease in patients with multiple myeloma. Cancer 2014; 120: pp. 618-623.</p><li><p>23. Letourneau D., Kaus M., Wong R., et. al.: Semiautomatic vertebrae visualization, detection, and identification for online palliative radiotherapy of bone metastases of the spine. Med Phys 2008; 35: pp. 367-376.</p><li><p>24. Homann G., Weisel K., Mustafa D.F., et. al.: Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: comparison with 5- and 1-mm axial images. Skeletal Radiol 2015; 44: pp. 971-979.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-24/'>Volume 24</a>, <a href='/categories/issue-5/'>Issue 5</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Automated%20%E2%80%9CBone%20Subtraction%E2%80%9D%20Image%20Analysis%20Software%20Package%20for%20Improved%20and%20Faster%20CT%20Monitoring%20of%20Longitudinal%20Spine%20Involvement%20in%20Patients%20with%20Multiple%20Myeloma%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fautomated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Automated%20%E2%80%9CBone%20Subtraction%E2%80%9D%20Image%20Analysis%20Software%20Package%20for%20Improved%20and%20Faster%20CT%20Monitoring%20of%20Longitudinal%20Spine%20Involvement%20in%20Patients%20with%20Multiple%20Myeloma%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fautomated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fautomated-bone-subtraction-image-analysis-software-package-for-improved-and-faster-ct-monitoring-o%2F&text=Automated%20%E2%80%9CBone%20Subtraction%E2%80%9D%20Image%20Analysis%20Software%20Package%20for%20Improved%20and%20Faster%20CT%20Monitoring%20of%20Longitudinal%20Spine%20Involvement%20in%20Patients%20with%20Multiple%20Myeloma%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/3d-printing-of-preoperative-simulation-models-of-a-splenic-artery-aneurysm/"><div class="card-body"> <em class="small" data-ts="1493571600" data-df="ll" > Apr 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>3D Printing of Preoperative Simulation Models of a Splenic Artery Aneurysm</h3><div class="text-muted small"><p> Rationale and Objectives Three-dimensional (3D) printing is attracting increasing attention in the medical field. This study aimed to apply 3D printing to the production of hollow splenic artery a...</p></div></div></a></div><div class="card"> <a href="/posts/a-clinically-meaningful-interpretation-of-the-prospective-investigation-of-pulmonary-embolism-diagno/"><div class="card-body"> <em class="small" data-ts="1493571600" data-df="ll" > Apr 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) Scintigraphic Data</h3><div class="text-muted small"><p> Rationale and Objectives Pulmonary embolism (PE) is a common condition associated with significant morbidity and mortality. Diagnostic test characteristics reported in terms of sensitivity and spe...</p></div></div></a></div><div class="card"> <a href="/posts/a-tribute-to-mark-richard-robbin-md/"><div class="card-body"> <em class="small" data-ts="1493571600" data-df="ll" > Apr 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Tribute to Mark Richard Robbin, MD</h3><div class="text-muted small"><p> Open full size image In January 2017, we lost a friend, colleague, and advocate for radiology education, Mark Robbin. Many of us know Mark through his leadership roles in musculoskeletal radiology...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/a-tribute-to-mark-richard-robbin-md/" class="btn btn-outline-primary" prompt="Older"><p>A Tribute to Mark Richard Robbin, MD</p></a> <a href="/posts/automated-and-manual-measurements-of-the-aortic-annulus-with-ecg-gated-cardiac-ct-angiography-prior/" class="btn btn-outline-primary" prompt="Newer"><p>Automated and Manual Measurements of the Aortic Annulus with ECG-Gated Cardiac CT Angiography Prior to Transcatheter Aortic Valve Replacement</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
